prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, DIAGNOSIS. (A) RIGHT AXILLARY SENTINEL LYMPH NODE #1, BIOPSY: One lymph node, no tumor present (0/1). (See Comment). (B) RIGHT BREAST, SEGMENTAL MASTECTOMY: INVASIVE DUCTAL CARCINOMA, INTERMEDIATE NUCLEAR GRADE. (SEE COMMENT). INVASIVE TUMOR MEASURES 1.6 CM IN THE LARGEST DIMENSION. No definite lymphovascular invasion identified. ASSOCIATED DUCTAL CARCINOMA IN SITU (DCIS), INTERMEDIATE GRADE, SOLID AND CRIBRIFORM TYPES. WITH FOCAL NECROSIS, COMPRISING LESS THAN 10% OF TUMOR AND FOCALLY EXTENDING INTO. ADJACENT BREAST TISSUE. Focal fibrosis and hemosiderin deposition consistent with previous biopsy procedure. Tumor does not approach surgical margins. Entire report and diagnosis completed by I. COMMENT. Although the invasive tumor appears otherwise to be of low nuclear grade, scattered mitotic figures are readily identified. There is some prominent retraction artifact, making assessment of lymphovascular invasion difficult. No definite lymphovascular. asion is identified. The tumor has a central area of sclerosis comprising approximately 20% of the tumor. This is not as. Prominent as in the tumors described as "centrally necrotizing carcinomas" or "carcinomas with large central acellular zones," but. the clinical significance is unclear. Immunostains for keratin performed on the sentinel lymph node (blocks A1-A2) are negative. Tumor marker studies were reported previously (see. GROSS DESCRIPTION. (A) SENTINEL LYMPH NODE #1, BLUE, EX VIVO 110, IN VIVO 105 - A single lymph node (1.0 x 1.0 x 0.6 cm). The specimen. is serially sectioned and entirely submitted in A1-A2. (B) RIGHT SEGMENTAL MASTECTOMY, SHORT STITCH SUPERIOR, LONG STITCH LATERAL, PURPLE INK DEEP. MARGIN - An oriented right segmental mastectomy specimen (6.0 x 6.0 x 5.0 cm). The specimen is oriented with a short stitch. superior, long stitch lateral, and purple ink at the deep margin. Attached to the specimen is an unremarkable ellipse of skin (3.5 x. 1.5 cm). The specimen is serially sectioned sequentially from lateral to medial into 10 slices. In the middle portion of the specimen,. centrally located in the slices, a solid white firm lesion (1.5 x 1.3 cm) is present approximately 1.5 cm from the superior margin, 1.5. cm from the inferior margin, 1.0 cm from the superficial margin, and 2.5 cm from the deep margin. The remainder of the specimen appears grossly unremarkable. INK CODE: Superior - blue, inferior - green, superficial - yellow, medial and lateral - red, and deep - black. SECTION CODE: B1, tumor; B2, skin and superficial; B3, superior margin; B4, inferior margin; B5, deep margin; B6, B7,. tumor; B8, adjacent to the tumor, more medial; B9, adjacent to the tumor, more lateral; B10, B11, representative sections,. perpendicular, most lateral aspect; B12, B13, representative sections, perpendicular, most medial aspect. LINICAL HISTORY. Right breast cancer. SNOMED CODES. 04050, M-85003. "Some tests reported here may have been developed and performance characteristics determined by. These tests have not been specifically cleared or approved by the U.S. Food and Drug Administration.". Released by:

expanded version (tokens=1214) : 
 The breast pathology report indicates the following:

Histological classification
- Invasive ductal carcinoma (intermediate nuclear grade)
- Ductal carcinoma in situ (DCIS) (intermediate grade, solid and cribiform types)

Subtype 
- Luminal A

Description of necrosis
- Focal necrosis comprising less than 10% of the tumor and focally extending into adjacent breast tissue

Tumor infiltrating lymphocytes
- No mention in the report 

Histological grade
- Intermediate nuclear grade 

Nuclear grade
- Intermediate 

Lymphovascular invasion
- No definite lymphovascular invasion identified 

Calcification
- No mention in the report 

Receptor status
- No mention in the report 

IHC and ancillary testing results
- Immunostains for keratin performed on the sentinel lymph node (blocks A1-A2) are negative 
 
Additional comments
- The tumor appears to have a central area of sclerosis comprising approximately 20% of the tumor. 

- Scattered mitotic figures are readily identified in the invasive tumor, despite otherwise appearing low nuclear grade. 

- No definite lymphovascular invasion is identified, but assessment is difficult due to prominent retraction artifact. 

- Tumor does not approach surgical margins. 

- Previous tumor marker studies were reported previously. 

- Focal fibrosis and hemosiderin deposition are consistent with a previous biopsy procedure.

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=1377) : 
 The breast pathology report reveals intermediate-grade Luminal A invasive ductal carcinoma (1.6 cm), coexisting with intermediate-grade, solid and cribiform DCIS exhibiting focal necrosis in the adjacent tissue. No lymphovascular invasion is noted, mitotic figures with scarce scattered retraction artifacts are present. Negative keratin immunostains observed in sentinel nodes. Tumor marker studies were already reported earlier. Evaluated margins remain unaffected post-surgery; a central area of sclerosis comprising 20% of tumor surface exhibits no significance as "centrally necrotizing carcinoma."

